Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$2.28 - $3.5 $95,303 - $146,300
41,800 Added 1019.51%
45,900 $147,000
Q3 2023

Nov 07, 2023

BUY
$3.17 - $5.96 $12,997 - $24,436
4,100 New
4,100 $12,000
Q1 2023

May 12, 2023

BUY
$4.92 - $8.21 $16,728 - $27,914
3,400 New
3,400 $16,000
Q3 2022

Nov 07, 2022

BUY
$10.32 - $17.28 $141,384 - $236,736
13,700 New
13,700 $147,000
Q2 2022

Aug 09, 2022

SELL
$6.78 - $12.28 $234,635 - $424,973
-34,607 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$7.65 - $15.29 $3,825 - $7,645
-500 Reduced 1.42%
34,607 $315,000
Q4 2021

Feb 11, 2022

BUY
$13.13 - $24.52 $460,954 - $860,823
35,107 New
35,107 $523,000
Q3 2021

Nov 09, 2021

SELL
$21.01 - $27.64 $109,252 - $143,728
-5,200 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$23.49 - $35.8 $122,147 - $186,159
5,200 New
5,200 $135,000
Q1 2021

May 14, 2021

SELL
$25.79 - $39.02 $3,043 - $4,604
-118 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$25.24 - $43.45 $2,978 - $5,127
118 New
118 $2,000
Q3 2020

Nov 16, 2020

SELL
$32.38 - $44.96 $6,476 - $8,992
-200 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$18.39 - $54.04 $3,678 - $10,808
200 New
200 $8,000
Q1 2020

May 13, 2020

SELL
$18.22 - $28.25 $25,508 - $39,550
-1,400 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$24.82 - $31.4 $34,748 - $43,960
1,400 New
1,400 $36,000
Q3 2019

Nov 12, 2019

SELL
$26.11 - $32.99 $93,996 - $118,764
-3,600 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$25.56 - $31.09 $92,016 - $111,924
3,600 New
3,600 $96,000

Others Institutions Holding ALLO

About Allogene Therapeutics, Inc.


  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $326M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.